{"title":"骨外骨肉瘤成像和免疫组织病理学特征的诊断挑战。","authors":"Jiro Ichikawa, Tomonori Kawasaki, Kojiro Onohara, Kaoru Aoki, Masanori Wako, Satoshi Ochiai, Tetsuo Hagino, Hirotaka Haro","doi":"10.1186/s12957-024-03583-3","DOIUrl":null,"url":null,"abstract":"<p><p>This correspondence addresses the article published by Nie et al. titled \"Primary extraskeletal osteosarcoma of sigmoid mesocolon: a case report and a review of the literature\". Their report highlighted an extremely rare case of extraskeletal osteosarcoma (EO) in the sigmoid mesocolon that was diagnosed through imaging and histopathological findings. Diagnosing EO has certain challenges; one of them being the lack of characteristic image findings of EO and the other being the lack of appropriate immunohistochemical (IHC) markers in the histopathological findings. Recently, special AT-rich sequence-binding protein 2 (SATB2) has been proposed as an IHC marker for osteoblastic differentiation; however, it has low specificity. Some cases of EO may show findings such as mouse double minute protein 2 expression and deletion of histone H3 lysine 27 trimethylation (H3K27me3), which are similar to those of other soft tissue sarcomas. Therefore, it is essential to consider other soft tissue sarcomas, especially dedifferentiated liposarcoma, before the accurate diagnosis of EO.</p>","PeriodicalId":23856,"journal":{"name":"World Journal of Surgical Oncology","volume":"22 1","pages":"307"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577805/pdf/","citationCount":"0","resultStr":"{\"title\":\"Diagnostic challenges in imaging and immunohistopathological profiles in extraskeletal osteosarcoma.\",\"authors\":\"Jiro Ichikawa, Tomonori Kawasaki, Kojiro Onohara, Kaoru Aoki, Masanori Wako, Satoshi Ochiai, Tetsuo Hagino, Hirotaka Haro\",\"doi\":\"10.1186/s12957-024-03583-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This correspondence addresses the article published by Nie et al. titled \\\"Primary extraskeletal osteosarcoma of sigmoid mesocolon: a case report and a review of the literature\\\". Their report highlighted an extremely rare case of extraskeletal osteosarcoma (EO) in the sigmoid mesocolon that was diagnosed through imaging and histopathological findings. Diagnosing EO has certain challenges; one of them being the lack of characteristic image findings of EO and the other being the lack of appropriate immunohistochemical (IHC) markers in the histopathological findings. Recently, special AT-rich sequence-binding protein 2 (SATB2) has been proposed as an IHC marker for osteoblastic differentiation; however, it has low specificity. Some cases of EO may show findings such as mouse double minute protein 2 expression and deletion of histone H3 lysine 27 trimethylation (H3K27me3), which are similar to those of other soft tissue sarcomas. Therefore, it is essential to consider other soft tissue sarcomas, especially dedifferentiated liposarcoma, before the accurate diagnosis of EO.</p>\",\"PeriodicalId\":23856,\"journal\":{\"name\":\"World Journal of Surgical Oncology\",\"volume\":\"22 1\",\"pages\":\"307\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11577805/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"World Journal of Surgical Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s12957-024-03583-3\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Surgical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12957-024-03583-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
这封信函涉及 Nie 等人发表的题为 "乙状结肠系膜原发性骨外骨肉瘤:病例报告和文献综述 "的文章。他们的报告重点介绍了一例极为罕见的乙状结肠系膜外骨肉瘤(EO)病例,该病例是通过影像学和组织病理学检查结果确诊的。诊断 EO 有一定的难度,其一是缺乏 EO 的特征性影像学发现,其二是组织病理学发现中缺乏适当的免疫组化(IHC)标记物。最近,特殊富AT序列结合蛋白2(SATB2)被提出作为成骨细胞分化的IHC标记物,但其特异性较低。一些EO病例可能会出现小鼠双分化蛋白2表达和组蛋白H3赖氨酸27三甲基化(H3K27me3)缺失等结果,这些结果与其他软组织肉瘤相似。因此,在准确诊断EO之前,必须考虑其他软组织肉瘤,尤其是已分化的脂肪肉瘤。
Diagnostic challenges in imaging and immunohistopathological profiles in extraskeletal osteosarcoma.
This correspondence addresses the article published by Nie et al. titled "Primary extraskeletal osteosarcoma of sigmoid mesocolon: a case report and a review of the literature". Their report highlighted an extremely rare case of extraskeletal osteosarcoma (EO) in the sigmoid mesocolon that was diagnosed through imaging and histopathological findings. Diagnosing EO has certain challenges; one of them being the lack of characteristic image findings of EO and the other being the lack of appropriate immunohistochemical (IHC) markers in the histopathological findings. Recently, special AT-rich sequence-binding protein 2 (SATB2) has been proposed as an IHC marker for osteoblastic differentiation; however, it has low specificity. Some cases of EO may show findings such as mouse double minute protein 2 expression and deletion of histone H3 lysine 27 trimethylation (H3K27me3), which are similar to those of other soft tissue sarcomas. Therefore, it is essential to consider other soft tissue sarcomas, especially dedifferentiated liposarcoma, before the accurate diagnosis of EO.
期刊介绍:
World Journal of Surgical Oncology publishes articles related to surgical oncology and its allied subjects, such as epidemiology, cancer research, biomarkers, prevention, pathology, radiology, cancer treatment, clinical trials, multimodality treatment and molecular biology. Emphasis is placed on original research articles. The journal also publishes significant clinical case reports, as well as balanced and timely reviews on selected topics.
Oncology is a multidisciplinary super-speciality of which surgical oncology forms an integral component, especially with solid tumors. Surgical oncologists around the world are involved in research extending from detecting the mechanisms underlying the causation of cancer, to its treatment and prevention. The role of a surgical oncologist extends across the whole continuum of care. With continued developments in diagnosis and treatment, the role of a surgical oncologist is ever-changing. Hence, World Journal of Surgical Oncology aims to keep readers abreast with latest developments that will ultimately influence the work of surgical oncologists.